NBP
NovaBridge Biosciences
NASDAQ: NBP · HEALTHCARE · BIOTECHNOLOGY
$2.35
-1.67% today
Updated 2026-04-29
Market cap
$271.77M
P/E ratio
—
P/S ratio
25.39x
EPS (TTM)
$-0.48
Dividend yield
—
52W range
$1 – $7
Volume
0.9M
NovaBridge Biosciences (NBP) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-40.90%
ROA
-24.90%
Debt/equity
0.09x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | $11.56M | $-298.24M | 100.00% | -2,431.25% | -2,580.82% |
| 2018 | $53.78M | $-402.83M | 100.00% | -815.60% | -749.02% |
| 2019 | $30.00M | $-1.49B | 100.00% | -4,883.23% | -4,950.00% |
| 2020 | $1.54B | $470.92M | 100.00% | 10.08% | 30.53% |
| 2021 | $88.03M | $-2.33B | 47.25% | -2,353.06% | -2,648.70% |
| 2022 | $-10.70M | $-2.51B | 2,325.83% | 3,422.17% | 23,438.90% |
| 2023 | $4.49M | $-1.47B | 100.00% | -11,395.09% | -32,674.02% |
| 2024 | $0.00 | $-162.26M | — | — | — |
| 2025 | $0.00 | $-46.27M | — | — | — |